Oncology Nurse Edition Contact Us

Article

Editorial Inquiries:Anne Landry, Executive Editor Ph: 212-929-4624 Email: anne.landry@ubm.comContinuing Education: Marsha Peruo Ph: 201-984-6216 Email: marsha.peruo@cmellc.comEditorial Office: UBM Medica LLC 535 Connecticut Ave, Suite 300 Norwalk, CT 06854 Ph: 516-474-4766Publisher and Sales Contacts: Amy Birnbach Group Publisher Ph: 201-984-6265 Email: amy.birnbach@ubm.com Sarah Mifsud Account Manager Digital Media Ph: 203-523-7055 Email: sarah.mifsud@ubm.comWeb site Contact: Ian Ingram Web Editor Email: ian.ingram@ubm.com  

CONTACT US

Editorial Inquiries:
Anne Landry, Executive Editor
Ph: 212-929-4624
Email: anne.landry@ubm.comContinuing Education:
Marsha Peruo
Ph: 201-984-6216
Email: marsha.peruo@cmellc.comEditorial Office:
UBM Medica LLC
535 Connecticut Ave, Suite 300
Norwalk, CT 06854
Ph: 516-474-4766

Publisher and Sales Contacts:
Amy Birnbach
Group Publisher
Ph: 201-984-6265
Email: amy.birnbach@ubm.com

Sarah Mifsud
Account Manager
Digital Media
Ph: 203-523-7055
Email: sarah.mifsud@ubm.comWeb site Contact:
Ian Ingram
Web Editor
Email: ian.ingram@ubm.com
 

Recent Videos
Brett L. Ecker, MD, discusses the importance of multidisciplinary collaboration in improving patient outcomes in neuroendocrine tumors.
2 experts are featured in this series.
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Related Content